The Real Problem Is When Drugs Don't Get Published

Goldacre: Drug companies should put new drugs to a fair test. He says when they don't, the real bad guys are those who continue to accept weak data. Half of clinical trials never see the light of day that don't get published, he adds. Gold acre: Trials that show results that are so called statistically significant are more likely to get published.